More emphasis should be put on the advantages of providing HCV care for people who inject drugs in centralised rather than decentralised settings, possibly by expanding harm reduction programmes and integrating HCV services.
Poor cerebral collateral flow is associated with poor outcome after ischaemic stroke, and larger and faster infarct growth. Thus, therapeutic promotion of collateral flow may offer the chance to improve outcome.
How to manage immunosuppressive agents in patients with rheumatoid arthritis who will require surgery, in order to avoid complications after surgery while limiting perioperative disease flares, is a critical question.
Integrated care programmes can improve health-related quality of life, exercise capacity and hospital admissions in COPD patients.
An international peer-reviewed medical journal, established in 1871.
Newsletter for advertisers
Swiss Medical Weekly EMH Swiss Medical Publishers Ltd. Farnsburgerstrasse 8 CH-4132 Muttenz Tel. +41 (0)61 467 85 55 Fax +41 (0)61 467 85 56 e-mail: Editorial office
EMH MediaSchweizerische ÄrztezeitungSwiss Medical ForumPrimary and Hospital CareCardiovascular MedicineSwiss Archives of Neurology, Psychiatry and PsychotherapySynapseSwiss Medical Informatics